This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v0.2.0: STU 1 Ballot 2) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
<ValueSet xmlns="http://hl7.org/fhir"> <id value="valueset-oxaprozin"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a> version <code>02-Jul-2018</code><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>157381</td><td>Daypro</td><td/></tr><tr><td>32613</td><td>oxaprozin</td><td/></tr><tr><td>660767</td><td>Oxaprozin potassium</td><td/></tr><tr><td>207243</td><td>oxaprozin 600 MG Oral Tablet [Daypro]</td><td/></tr><tr><td>568030</td><td>oxaprozin 600 MG [Daypro]</td><td/></tr><tr><td>368765</td><td>oxaprozin Oral Tablet [Daypro]</td><td/></tr><tr><td>312132</td><td>oxaprozin 600 MG Oral Tablet</td><td/></tr><tr><td>349188</td><td>oxaprozin 600 MG Delayed Release Oral Capsule</td><td/></tr><tr><td>316413</td><td>oxaprozin 600 MG</td><td/></tr><tr><td>373169</td><td>oxaprozin Oral Tablet</td><td/></tr><tr><td>378275</td><td>oxaprozin Delayed Release Oral Capsule</td><td/></tr><tr><td>1160122</td><td>oxaprozin Oral Product</td><td/></tr><tr><td>1160123</td><td>oxaprozin Pill</td><td/></tr><tr><td>1168832</td><td>Daypro Oral Product</td><td/></tr><tr><td>1168833</td><td>Daypro Pill</td><td/></tr></table></li></ul></div> </text> <url value="http://hl7.org/fhir/uv/pddi/ValueSet/valueset-oxaprozin"/> <version value="0.2.0"/> <name value="Valueset_oxaprozin"/> <title value="Oxaprozin Medications Value Set"/> <status value="draft"/> <date value="2018-07-02"/> <publisher value="PDDI CDS"/> <contact> <name value="Richard Boyce"/> </contact> <description value="ValueSet containing drug identifiers for oxaprozin."/> <jurisdiction> <coding> <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/> <code value="001"/> <display value="World"/> </coding> </jurisdiction> <copyright value="Attribution CC BY"/> <compose> <include> <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/> <version value="02-Jul-2018"/> <concept> <code value="157381"/> <display value="Daypro"/> </concept> <concept> <code value="32613"/> <display value="oxaprozin"/> </concept> <concept> <code value="660767"/> <display value="Oxaprozin potassium"/> </concept> <concept> <code value="207243"/> <display value="oxaprozin 600 MG Oral Tablet [Daypro]"/> </concept> <concept> <code value="568030"/> <display value="oxaprozin 600 MG [Daypro]"/> </concept> <concept> <code value="368765"/> <display value="oxaprozin Oral Tablet [Daypro]"/> </concept> <concept> <code value="312132"/> <display value="oxaprozin 600 MG Oral Tablet"/> </concept> <concept> <code value="349188"/> <display value="oxaprozin 600 MG Delayed Release Oral Capsule"/> </concept> <concept> <code value="316413"/> <display value="oxaprozin 600 MG"/> </concept> <concept> <code value="373169"/> <display value="oxaprozin Oral Tablet"/> </concept> <concept> <code value="378275"/> <display value="oxaprozin Delayed Release Oral Capsule"/> </concept> <concept> <code value="1160122"/> <display value="oxaprozin Oral Product"/> </concept> <concept> <code value="1160123"/> <display value="oxaprozin Pill"/> </concept> <concept> <code value="1168832"/> <display value="Daypro Oral Product"/> </concept> <concept> <code value="1168833"/> <display value="Daypro Pill"/> </concept> </include> </compose> </ValueSet>